Code of Practice for the Pharmaceutical Industry 2021/

Abstract

The Code of Practice for the Pharmaceutical Industry 2021 is a comprehensive regulatory framework issued by the Association of the British Pharmaceutical Industry (ABPI) and administered by the Prescription Medicines Code of Practice Authority (PMCPA). It sets out ethical and professional standards for the conduct of pharmaceutical companies in the United Kingdom, focusing on the promotion of prescription medicines, interactions with healthcare professionals, and communication with patients and the public.

The 2021 Code emphasizes the principles of integrity, transparency, accountability, and patient safety, aiming to ensure that all promotional and educational activities are accurate, balanced, and evidence-based. It covers key areas including:

Interactions with healthcare professionals: Guidance on meetings, hospitality, sponsorship, and collaborative activities to prevent undue influence on clinical decision-making.

Promotion and advertising: Standards for accurate, fair, and responsible marketing of medicines to healthcare professionals and the public.

Transparency and disclosure: Requirements for reporting transfers of value to healthcare professionals and organizations, ensuring public accountability.

Scientific exchange and education: Support for the dissemination of information about medicines for healthcare professional education, research collaboration, and public health purposes.

Patient engagement and support: Guidance on patient information, access programs, and ethical communication.

The Code provides a self-regulatory mechanism that complements statutory law, with the PMCPA responsible for investigating complaints and enforcing compliance. By establishing these standards, the Code promotes ethical behavior, public trust, and the responsible use of medicines, while safeguarding patients, healthcare professionals, and the broader healthcare system.